Clinical Study Protocol M16-000 A Multicenter Randomized Double Blind Placebo Controlled 52 Week Maintenance and an Open Label Extension Study

Grants and Contracts Details

StatusFinished
Effective start/end date7/7/17 → 11/29/21

Funding

  • AbbVie Incorporated: $57,697.00